The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
Carlo Perricone, Paola Triggianese, Elena Bartoloni, Giacomo Cafaro, Angelo Francesco Bonifacio, Roberto Bursi, Roberto Perricone, Roberto Gerli
Topics & Concepts
HydroxychloroquineMedicinePandemicOutbreakPneumoniaIntensive care unitCoronavirusCoronavirus disease 2019 (COVID-19)Viral pneumoniaDiseaseChloroquineImmunologyTumor necrosis factor alphaInfectious disease (medical specialty)VirologyIntensive care medicineInternal medicineMalariaCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19